Trial Profile
Clinical trial of ADCT 401 in patients with hormone-refractory prostate cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs MEDI 3726 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 20 May 2014 New trial record